CD26 is a widely distributed 110 kD cell-surface glycoprotein with kno
wn dipeptidyl-peptidase IV (DPP-IV) activity in its extracellular doma
in. This ecto-enzyme is capable of cleaving amino terminal dipeptides
from polypeptides with either L-proline or L-alanine in the penultimat
e position. On human T cells, CD26 expression appears late in thymic d
ifferentiation and is preferentially restricted to the CD4(+) helper/m
emory population, and CD26 can deliver a potent co-stimulatory T-cell
activation signal. The cDNA sequence of CD26 predicts a type II membra
ne protein with only 6 amino acids in its cytoplasmic region, suggesti
ng that, in addition to DPP-IV enzyme activity, other signal-inducing
molecules may be associated with CD26. Considerable evidence exists th
at CD26 interacts, presumably in its extracellular domain, with both C
D45, a protein tyrosine phosphatase, and adenosine deaminase (ADA), ea
ch of which is capable of functioning in a signal transduction pathway
In addition, CD26 is the receptor for ADA, and ADA on the cell surfac
e is involved in an important immunoregulatory mechanism by which rele
ased ADA binds to the cell-surface ADA. This multifunctional molecule
may be involved in cell migration and the HIV-l-associated loss of CD4
(+) cells through the process of programmed cell death. Thus, CD26 app
ears to play a key role in a number of aspects of lymphocyte function.